Alprostadil (Caverject, Viridal Duo, Vitaros)

BNF:: 7.4.5
Status:: Grey - after consultant/specialist initiation
Decision Date:: September 2014

Comments

As per SLS criteria, usually 2nd line to a PDE type 5 inhibitor

Brown Drug Classifications

5: Less cost-effective than current standard therapy